Pesquisa | BVS Violência e Saúde

1.

Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.

Ingle, James N; Kalari, Krishna R; Barman, Poulami; Shepherd, Lois E; Ellis, Matthew J; Goss, Paul E; Buzdar, Aman U; Robson, Mark E; Cairns, Junmei; Carlson, Erin E; Eyman Casey, Abraham; Hoskin, Tanya L; Goodnature, Barbara A; Haddad, Tufia C; Goetz, Matthew P; Weinshilboum, Richard M; Wang, Liewei.

Pharmacogenet Genomics ; 31(1): 1-9, 2021 01.

Artigo em Inglês | MEDLINE | ID: mdl-32649577

2.

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.

Yam, Clinton; Murthy, Rashmi K; Valero, Vicente; Szklaruk, Janio; Shroff, Girish S; Stalzer, Carol J; Buzdar, Aman U; Murray, James L; Yang, Wei; Hortobagyi, Gabriel N; Moulder, Stacy L; Arun, Banu.

Invest New Drugs ; 36(2): 299-306, 2018 04.

Artigo em Inglês | MEDLINE | ID: mdl-29374384

3.

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

Dudenkov, Tanda M; Ingle, James N; Buzdar, Aman U; Robson, Mark E; Kubo, Michiaki; Ibrahim-Zada, Irada; Batzler, Anthony; Jenkins, Gregory D; Pietrzak, Tracy L; Carlson, Erin E; Barman, Poulami; Goetz, Matthew P; Northfelt, Donald W; Moreno-Aspita, Alvaro; Williard, Clark V; Kalari, Krishna R; Nakamura, Yusuke; Wang, Liewei; Weinshilboum, Richard M.

Breast Cancer Res Treat ; 164(1): 189-199, 2017 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-28429243

4.

Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426).

Warner, Erica T; Ballman, Karla V; Strand, Carrie; Boughey, Judy C; Buzdar, Aman U; Carey, Lisa A; Sikov, William M; Partridge, Ann H.

Breast Cancer Res Treat ; 159(1): 109-18, 2016 08.

Artigo em Inglês | MEDLINE | ID: mdl-27449492

5.

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.

Strasser-Weippl, Kathrin; Horick, Nora; Smith, Ian E; O'Shaughnessy, Joyce; Ejlertsen, Bent; Boyle, Frances; Buzdar, Aman U; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I; Lindquist, Deborah; Rappold, Erica; Finkelstein, Dianne M; Goss, Paul E.

Breast Cancer Res ; 17: 56, 2015 Apr 16.

Artigo em Inglês | MEDLINE | ID: mdl-25888246

6.

Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial.

Buzdar, Aman U; Suman, Vera J; Meric-Bernstam, Funda; Leitch, A Marilyn; Ellis, Matthew J; Boughey, Judy C; Unzeitig, Gary; Royce, Melanie; McCall, Linda M; Ewer, Michael S; Hunt, Kelly K.

Lancet Oncol ; 14(13): 1317-25, 2013 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-24239210

7.

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.

Goss, Paul E; Smith, Ian E; O'Shaughnessy, Joyce; Ejlertsen, Bent; Kaufmann, Manfred; Boyle, Frances; Buzdar, Aman U; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Moy, Beverly; Piccart-Gebhart, Martine; Pritchard, Kathleen I; Lindquist, Deborah; Chavarri-Guerra, Yanin; Aktan, Gursel; Rappold, Erica; Williams, Lisa S; Finkelstein, Dianne M.

Lancet Oncol ; 14(1): 88-96, 2013 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-23234763

8.

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.

Jung, Eun-Jung; Santarpia, Libero; Kim, Juyeon; Esteva, Francisco J; Moretti, Erica; Buzdar, Aman U; Di Leo, Angelo; Le, Xiao-Feng; Bast, Robert C; Park, Soon-Tae; Pusztai, Lajos; Calin, George A.

Cancer ; 118(10): 2603-14, 2012 May 15.

Artigo em Inglês | MEDLINE | ID: mdl-22370716

9.

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.

Bayraktar, Soley; Gonzalez-Angulo, Ana M; Lei, Xiudong; Buzdar, Aman U; Valero, Vicente; Melhem-Bertrandt, Amal; Kuerer, Henry M; Hortobagyi, Gabriel N; Sahin, Aysegul A; Meric-Bernstam, Funda.

Cancer ; 118(9): 2385-93, 2012 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-21953213

10.

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.

Yam, Clinton; Abuhadra, Nour; Sun, Ryan; Adrada, Beatriz E; Ding, Qing-Qing; White, Jason B; Ravenberg, Elizabeth E; Clayborn, Alyson R; Valero, Vicente; Tripathy, Debu; Damodaran, Senthilkumar; Arun, Banu K; Litton, Jennifer K; Ueno, Naoto T; Murthy, Rashmi K; Lim, Bora; Baez, Luis; Li, Xiaoxian; Buzdar, Aman U; Hortobagyi, Gabriel N; Thompson, Alistair M; Mittendorf, Elizabeth A; Rauch, Gaiane M; Candelaria, Rosalind P; Huo, Lei; Moulder, Stacy L; Chang, Jeffrey T.

Clin Cancer Res ; 28(13): 2878-2889, 2022 07 01.

Artigo em Inglês | MEDLINE | ID: mdl-35507014

11.

Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia.

Ferrajoli, Alessandra; Buzdar, Aman U; Dejesus, Yvette; Cheng, Lee; Michaud, Laura B; Rodriguez, Maria A.

Cancer ; 117(14): 3268-75, 2011 Jul 15.

Artigo em Inglês | MEDLINE | ID: mdl-21264831

12.

Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.

Yi, Min; Buchholz, Thomas A; Meric-Bernstam, Funda; Bedrosian, Isabelle; Hwang, Rosa F; Ross, Merrick I; Kuerer, Henry M; Luo, Sheng; Gonzalez-Angulo, Ana M; Buzdar, Aman U; Symmans, W Fraser; Feig, Barry W; Lucci, Anthony; Huang, Eugene H; Hunt, Kelly K.

Ann Surg ; 253(3): 572-9, 2011 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-21209588

13.

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.

Arun, Banu K; Dhinghra, Kapil; Valero, Vicente; Kau, Shu-Wan; Broglio, Kristine; Booser, Daniel; Guerra, Laura; Yin, Guosheng; Walters, Ronald; Sahin, Aysegul; Ibrahim, Nuhad; Buzdar, Aman U; Frye, Debbie; Sneige, Nour; Strom, Eric; Ross, Merrick; Theriault, Richard L; Vadhan-Raj, Saroj; Hortobagyi, Gabriel N.

Oncologist ; 16(11): 1527-34, 2011.

Artigo em Inglês | MEDLINE | ID: mdl-22042783

14.

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control.

Albert, Jeffrey M; Buzdar, Aman U; Guzman, Reina; Allen, Pamela K; Strom, Eric A; Perkins, George H; Woodward, Wendy A; Hoffman, Karen E; Tereffe, Welela; Hunt, Kelly K; Buchholz, Thomas A; Oh, Julia L.

Breast Cancer Res Treat ; 128(2): 421-7, 2011 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-21553292

15.

Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.

Mazouni, Chafika; Baggerly, Keith; Hawke, David; Tsavachidis, Spyros; André, Fabrice; Buzdar, Aman U; Martin, Pierre-Marie; Kobayashi, Ryuji; Pusztai, Lajos.

Proteomics ; 10(19): 3525-32, 2010 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-20827732

16.

Evolving novel anti-HER2 strategies.

Jones, Kellie L; Buzdar, Aman U.

Lancet Oncol ; 10(12): 1179-87, 2009 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-19959074

17.

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.

Cairns, Junmei; Ingle, James N; Dudenkov, Tanda M; Kalari, Krishna R; Carlson, Erin E; Na, Jie; Buzdar, Aman U; Robson, Mark E; Ellis, Matthew J; Goss, Paul E; Shepherd, Lois E; Goodnature, Barbara; Goetz, Matthew P; Weinshilboum, Richard M; Li, Hu; Bari, Mehrab Ghanat; Wang, Liewei.

JCI Insight ; 5(16)2020 08 20.

Artigo em Inglês | MEDLINE | ID: mdl-32701512

18.

Meta-analysis: selective estrogen-receptor modulators reduce breast cancer incidence.

Buzdar, Aman U.

Ann Intern Med ; 159(6): JC9, 2013 Sep 17.

Artigo em Inglês | MEDLINE | ID: mdl-24042392

19.

Combination endocrine treatments unproven in breast cancer.

Buzdar, Aman U.

Lancet Oncol ; 14(10): 917-8, 2013 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-23902873

20.

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.

Sestak, Ivana; Cuzick, Jack; Sapunar, Francisco; Eastell, Richard; Forbes, John F; Bianco, Angelo R; Buzdar, Aman U.

Lancet Oncol ; 9(9): 866-72, 2008 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-18703382

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: